Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 1320 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regular (Sales), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regelmatig (Verkoop), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regolare (vendite), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Director, Policy Regular, Full time | Other | Japan | Toranomon (NPKK Head Office) | Jan 22, 2026 |
| Senior Lead or Lead, Public Affairs Regular, Full time | Other | Japan | Toranomon (NPKK Head Office) | Jan 22, 2026 |
| Director, Social Impact & Novartis Foundation (Japan) for the Promotion of Science Regular, Full time | Other | Japan | Toranomon (NPKK Head Office) | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regular (Sales), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Manager Scientific Writing Regular, Full time | Marketing | India | Hyderabad (Office) | Jan 22, 2026 |
| Senior Manager REFS Finance Regular, Full time | Finance | India | Hyderabad (Office) | Jan 22, 2026 |
| Senior Manager, Asset Management & Reliability Engineering Regular, Full time | Production / Manufacturing | USA | Morris Plains | Jan 22, 2026 |
Pagination
- ‹ Previous page
- 1
- …
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- › Next page
Adverse Event Reporting
We encourage using the following electronic reporting tool for reporting into the safety database directly: https://www.report.novartis.com/
If electronic reporting tool is not working – please use the following Generic mailbox: [email protected]
CISCO: +20 2 22861000: Press 3 for Adverse Event Reporting